Free Trial

Barclays Issues Positive Forecast for Agilent Technologies (NYSE:A) Stock Price

Agilent Technologies logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Barclays raised its price target on Agilent Technologies from $140 to $145 and kept an overweight rating, implying about 7.4% upside from the current price.
  • Other major analysts remain broadly positive, with multiple firms reiterating buy-equivalent ratings and the consensus view still sitting at Buy with a $161.07 average price target.
  • Agilent also posted better-than-expected quarterly results, including EPS of $1.49 versus $1.41 expected and revenue up 10% year over year, while raising its full-year 2026 guidance.
  • Five stocks we like better than Agilent Technologies.

Agilent Technologies (NYSE:A - Get Free Report) had its price target increased by stock analysts at Barclays from $140.00 to $145.00 in a report released on Thursday,Benzinga reports. The brokerage currently has an "overweight" rating on the medical research company's stock. Barclays's price objective suggests a potential upside of 7.43% from the stock's current price.

A number of other brokerages have also recently commented on A. UBS Group dropped their price target on Agilent Technologies from $180.00 to $165.00 and set a "buy" rating on the stock in a research report on Thursday, February 26th. Wells Fargo & Company decreased their price objective on shares of Agilent Technologies from $165.00 to $160.00 and set an "overweight" rating for the company in a report on Thursday. TD Cowen cut their target price on Agilent Technologies from $170.00 to $157.00 and set a "buy" rating on the stock in a research note on Thursday, February 26th. Morgan Stanley cut their target price on Agilent Technologies from $180.00 to $160.00 and set an "overweight" rating on the stock in a research note on Tuesday, March 3rd. Finally, Royal Bank Of Canada began coverage on Agilent Technologies in a research note on Wednesday. They set an "outperform" rating and a $153.00 target price on the stock. Two research analysts have rated the stock with a Strong Buy rating, thirteen have given a Buy rating and one has issued a Hold rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Buy" and a consensus price target of $161.07.

Check Out Our Latest Stock Report on Agilent Technologies

Agilent Technologies Stock Up 16.5%

Shares of NYSE:A traded up $19.13 during trading on Thursday, hitting $134.97. The stock had a trading volume of 2,082,453 shares, compared to its average volume of 2,184,981. Agilent Technologies has a 12 month low of $108.35 and a 12 month high of $160.27. The company has a market capitalization of $38.14 billion, a PE ratio of 29.70, a PEG ratio of 2.42 and a beta of 1.22. The firm's fifty day moving average is $114.99 and its 200 day moving average is $128.79. The company has a quick ratio of 1.59, a current ratio of 2.07 and a debt-to-equity ratio of 0.44.

Agilent Technologies (NYSE:A - Get Free Report) last issued its quarterly earnings results on Wednesday, May 27th. The medical research company reported $1.49 EPS for the quarter, topping analysts' consensus estimates of $1.41 by $0.08. Agilent Technologies had a return on equity of 24.49% and a net margin of 18.26%.The firm had revenue of $1.84 billion for the quarter, compared to analysts' expectations of $1.80 billion. During the same period in the previous year, the firm posted $1.31 EPS. The business's revenue for the quarter was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. Analysts anticipate that Agilent Technologies will post 5.95 EPS for the current fiscal year.

Hedge Funds Weigh In On Agilent Technologies

Institutional investors have recently bought and sold shares of the stock. SHP Wealth Management purchased a new stake in Agilent Technologies in the 4th quarter worth $26,000. Core Wealth Advisors LLC purchased a new position in shares of Agilent Technologies during the fourth quarter valued at about $26,000. Board of the Pension Protection Fund purchased a new position in shares of Agilent Technologies during the fourth quarter valued at about $27,000. Navalign LLC purchased a new position in shares of Agilent Technologies during the fourth quarter valued at about $27,000. Finally, MV Capital Management Inc. bought a new position in shares of Agilent Technologies in the 4th quarter valued at about $28,000.

Agilent Technologies News Roundup

Here are the key news stories impacting Agilent Technologies this week:

  • Positive Sentiment: Agilent beat Wall Street’s Q2 expectations, reporting adjusted EPS of $1.49 versus estimates around $1.41 and revenue of $1.83 billion, above forecasts, with revenue up 10% year over year. Agilent Reports Second-Quarter Fiscal Year 2026 Financial Results
  • Positive Sentiment: The company raised its full-year 2026 profit outlook and also issued Q3 guidance that points to continued growth, reinforcing confidence in demand for its lab tools and diagnostic products. Agilent raises 2026 profit forecast on strong demand for lab tools
  • Positive Sentiment: Bank of America upgraded Agilent from neutral to buy, which typically helps sentiment because it signals improved confidence in the stock’s upside. Benzinga report on Bank of America upgrade
  • Positive Sentiment: RBC also initiated coverage with an outperform rating and a $153 price target, adding another bullish analyst call after earnings. Benzinga report on RBC coverage
  • Neutral Sentiment: Agilent also highlighted new product launches and digital-lab tools, including OpenLab Sync and new GC systems, which support the longer-term growth story but are less likely to move the stock immediately. Agilent Introduces OpenLab Sync

About Agilent Technologies

(Get Free Report)

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company's product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.

Further Reading

Analyst Recommendations for Agilent Technologies (NYSE:A)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Agilent Technologies Right Now?

Before you consider Agilent Technologies, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.

While Agilent Technologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Related Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines